mRNA Vaccines dominated the market in 2024, accounting for over US$ 36 billion in revenues. Pfizer, Moderna, and BioNTech ...
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a ...
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based ...
For decades, cancer has been spoken of in hushed tones across the world, a death sentence for millions, especially in regions ...
In a chaotic meeting, ACIP voted not to recommend a prescription requirement for Covid-19 vaccines. Some panelists seemed unaware of the point of the meeting, while others went on strange tangents.
The vaccine advisory group ACIP, not all members of which seemed to know what the group does, recommended to the CDC that ...
Zacks Investment Research on MSN
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
An updated edition of the July 30, 2025, article. Genomics involves a thorough study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). It involves understanding how genes ...
Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...
Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.
1don MSN
Novel gene editing technology enables selective destruction of cancer cell DNA using fewer targets
Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...
By upregulating the expression of the lone functioning copy of SCN2A, scientists addressed deficient brain signaling and reduced seizures.
The Chosun Ilbo on MSN
KAIST, Korea Research Institute Develop World's First Dual-Mode CRISPR
KAIST and the Korea Research Institute of Chemical Technology have jointly developed the world’s first new ‘CRISPR gene-editing technology (CRISPR)’ capable of simultaneously turning genes on and off.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results